Aridis Pharmaceuticals Inc. logo

Aridis Pharmaceuticals Inc.

Sector: 
Healthcare
   

Industry: 
Biotechnology

1.13
 
USD
  
-0.04
  
(-3.42%)
Optionable: No  Market Cap: 21 M  90-day average vol: 60,428

Previous close: 1.17  Open: 1.17  Bid: 1.24  Ask: 1.24
52 week range    
0.88   
   7.69
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Thursday 30th June 2022
37
MarketXLS Rank marketxls
40
Value marketxls
30
Technical marketxls
42
Quality marketxls

Search for a stock
Are you?
twitterstocktwits
Chart
Financials

ARDS Income Statement

Annual

Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21
Total revenues2 M8600003 M1 M00
Cost of sales2 M-62000-283000-338000-337000-435000
Gross operating profit3420008600003 M1 M00
Selling Gen & administrative expense2 M3 M4 M6 M5 M6 M
Research & development expense6 M17 M23 M24 M17 M37 M
Operating income-8 M-20 M-24 M-29 M-22 M-43 M
floaterest income000000
floaterest expense000000
Other income net-172000-5 M2 M-951000-9000763000
Pre-tax Income (EBT)-8 M-25 M-22 M-30 M-22 M-42 M
Income taxes000000
Net income from total operations-8 M-25 M-22 M-30 M-22 M-42 M
Minority floaterest000000
Total net income-8 M-25 M-22 M-30 M-22 M-42 M
Preferred dividends4650003 M1 MN/AN/A4 M
Net income available for common-9 M-27 M-23 M-30 M-22 M-42 M
Depreciation2300062000283000338000337000435000
Amortization000000
Operating income before depreciation (EBITDA)-8 M-20 M-24 M-29 M-22 M-42 M
Total Income available for floaterest expense (EBIT)000000
Basic EPS total-1.13-3.48-7.45-3.51-2.44-3.77
Diluted EPS total-1.13-3.48-7.45-3.51-2.44-3.77
Top MarketXLS Rank stocks

Stand with Ukraine

As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.

For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention

From all of us at MarketXLS, thank you!